vs
Side-by-side financial comparison of GoPro, Inc. (GPRO) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
GoPro, Inc. is the larger business by last-quarter revenue ($201.7M vs $158.6M, roughly 1.3× Stoke Therapeutics, Inc.). On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 0.4%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $15.0M).
GoPro, Inc. is an American technology company founded in 2002 by Nick Woodman. It manufactures action cameras and develops its own mobile apps and video-editing software. Founded as Woodman Labs, Inc, the company is based in San Mateo, California.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
GPRO vs STOK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $201.7M | $158.6M |
| Net Profit | — | $112.9M |
| Gross Margin | 31.8% | — |
| Operating Margin | -4.1% | 70.2% |
| Net Margin | — | 71.2% |
| Revenue YoY | 0.4% | 3661.1% |
| Net Profit YoY | — | 528.0% |
| EPS (diluted) | $-0.06 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $201.7M | — | ||
| Q3 25 | $162.9M | — | ||
| Q2 25 | $152.6M | — | ||
| Q1 25 | $134.3M | $158.6M | ||
| Q4 24 | $200.9M | $22.6M | ||
| Q3 24 | $258.9M | — | ||
| Q2 24 | $186.2M | — | ||
| Q1 24 | $155.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | $-21.3M | — | ||
| Q2 25 | $-16.4M | — | ||
| Q1 25 | $-46.7M | $112.9M | ||
| Q4 24 | — | $-10.5M | ||
| Q3 24 | $-8.2M | — | ||
| Q2 24 | $-47.8M | — | ||
| Q1 24 | $-339.1M | — |
| Q4 25 | 31.8% | — | ||
| Q3 25 | 35.1% | — | ||
| Q2 25 | 35.8% | — | ||
| Q1 25 | 32.1% | — | ||
| Q4 24 | 34.7% | — | ||
| Q3 24 | 35.5% | — | ||
| Q2 24 | 30.5% | — | ||
| Q1 24 | 34.1% | — |
| Q4 25 | -4.1% | — | ||
| Q3 25 | -9.8% | — | ||
| Q2 25 | -9.2% | — | ||
| Q1 25 | -33.7% | 70.2% | ||
| Q4 24 | -19.5% | -60.4% | ||
| Q3 24 | -3.1% | — | ||
| Q2 24 | -25.0% | — | ||
| Q1 24 | -26.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | -13.0% | — | ||
| Q2 25 | -10.8% | — | ||
| Q1 25 | -34.8% | 71.2% | ||
| Q4 24 | — | -46.4% | ||
| Q3 24 | -3.2% | — | ||
| Q2 24 | -25.7% | — | ||
| Q1 24 | -218.1% | — |
| Q4 25 | $-0.06 | — | ||
| Q3 25 | $-0.13 | — | ||
| Q2 25 | $-0.10 | — | ||
| Q1 25 | $-0.30 | $1.90 | ||
| Q4 24 | $-0.22 | $-0.15 | ||
| Q3 24 | $-0.05 | — | ||
| Q2 24 | $-0.31 | — | ||
| Q1 24 | $-2.24 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $49.7M | $274.8M |
| Total DebtLower is stronger | $44.3M | — |
| Stockholders' EquityBook value | $76.5M | $350.1M |
| Total Assets | $428.0M | $406.9M |
| Debt / EquityLower = less leverage | 0.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $49.7M | — | ||
| Q3 25 | $152.8M | — | ||
| Q2 25 | $58.6M | — | ||
| Q1 25 | $69.6M | $274.8M | ||
| Q4 24 | $102.8M | $128.0M | ||
| Q3 24 | $130.2M | — | ||
| Q2 24 | $133.0M | — | ||
| Q1 24 | $133.7M | — |
| Q4 25 | $44.3M | — | ||
| Q3 25 | $43.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $93.1M | — | ||
| Q2 24 | $92.9M | — | ||
| Q1 24 | $92.7M | — |
| Q4 25 | $76.5M | — | ||
| Q3 25 | $80.5M | — | ||
| Q2 25 | $97.9M | — | ||
| Q1 25 | $110.0M | $350.1M | ||
| Q4 24 | $151.7M | $229.0M | ||
| Q3 24 | $183.9M | — | ||
| Q2 24 | $184.7M | — | ||
| Q1 24 | $224.9M | — |
| Q4 25 | $428.0M | — | ||
| Q3 25 | $538.6M | — | ||
| Q2 25 | $439.0M | — | ||
| Q1 25 | $462.5M | $406.9M | ||
| Q4 24 | $543.7M | $271.6M | ||
| Q3 24 | $661.6M | — | ||
| Q2 24 | $556.8M | — | ||
| Q1 24 | $575.8M | — |
| Q4 25 | 0.58× | — | ||
| Q3 25 | 0.55× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.51× | — | ||
| Q2 24 | 0.50× | — | ||
| Q1 24 | 0.41× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.6M | $131.8M |
| Free Cash FlowOCF − Capex | $15.0M | $131.7M |
| FCF MarginFCF / Revenue | 7.4% | 83.0% |
| Capex IntensityCapex / Revenue | 0.3% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | $-24.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.6M | — | ||
| Q3 25 | $12.2M | — | ||
| Q2 25 | $8.8M | — | ||
| Q1 25 | $-57.2M | $131.8M | ||
| Q4 24 | $-25.1M | $-23.2M | ||
| Q3 24 | $-2.2M | — | ||
| Q2 24 | $605.0K | — | ||
| Q1 24 | $-98.4M | — |
| Q4 25 | $15.0M | — | ||
| Q3 25 | $11.2M | — | ||
| Q2 25 | $8.3M | — | ||
| Q1 25 | $-58.5M | $131.7M | ||
| Q4 24 | $-25.5M | $-23.2M | ||
| Q3 24 | $-4.2M | — | ||
| Q2 24 | $-111.0K | — | ||
| Q1 24 | $-99.4M | — |
| Q4 25 | 7.4% | — | ||
| Q3 25 | 6.9% | — | ||
| Q2 25 | 5.4% | — | ||
| Q1 25 | -43.5% | 83.0% | ||
| Q4 24 | -12.7% | -102.7% | ||
| Q3 24 | -1.6% | — | ||
| Q2 24 | -0.1% | — | ||
| Q1 24 | -63.9% | — |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 1.0% | 0.1% | ||
| Q4 24 | 0.2% | 0.2% | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 0.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.17× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GPRO
| Subscription And Services | $106.3M | 53% |
| Other | $95.4M | 47% |
STOK
Segment breakdown not available.
